ARCHIVES

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

This article is from The Cancer Letter archive.

Vol. 37 No. 22 | June 3, 2011

Download PDF Visit The Full Archive

Related Articles

Ovariectomy Without HRT Increases Death Rate

September 29, 2006

NCAB Asks Government To Take Steps Aimed at Reducing Health Hazards From Cigarettes

December 21, 1973

No Cancer Letter For Two Weeks

August 10, 1990

In Brief: Justice Department Files Civil Suit To recover $25 Billion From Tobacco

September 24, 1999

In Brief: IU Cancer Center To Receive $15 Million for Breast Cancer

January 31, 2014

NIH advisors Review Intramural Program, Plan Spring Report

December 10, 1993